Dupilumab has been demonstrated to be an effective treatment for patients with moderate-to-severe atopic dermatitis (AD) in clinical trials. However, evidence of real-world experience with dupilumab in a broader population is limited to date.

Use of Dupilumab for 543 Adult Patients with Moderate-To-Severe Atopic Dermatitis: A Multicenter, Retrospective Study

Foti, C;Di Leo, E;Patruno, C;Macchia, L;Napolitano, M;Romita, P;Di Bona, D;Carbonara, M;
2020-01-01

Abstract

Dupilumab has been demonstrated to be an effective treatment for patients with moderate-to-severe atopic dermatitis (AD) in clinical trials. However, evidence of real-world experience with dupilumab in a broader population is limited to date.
File in questo prodotto:
File Dimensione Formato  
vol32issue2_4.pdf

accesso aperto

Descrizione: articolo principale
Tipologia: Documento in Versione Editoriale
Licenza: Creative commons
Dimensione 380.64 kB
Formato Adobe PDF
380.64 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11586/320104
Citazioni
  • ???jsp.display-item.citation.pmc??? 5
  • Scopus 47
  • ???jsp.display-item.citation.isi??? 43
social impact